J9198 Gemcitabine HCl - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Gemcitabine HCl

Brand Name:

Infugem

Strength:

100mg

HCPCS:

J9198

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Pyrimidine Analog

Oral (Y/N):

No

FDA Approval Year:

2018

FDA Discontinuation Year:

CMS Effective Date:

July 1, 2020

CMS Discontinuation Date:

Status:

In Use